Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leukemia

Showing results (321-330 of 13,978) with videos related to

Pageof 1,398
Sort By:
Leukemia|June 25, 2011
MicroRNAs in acute leukemia: from biological players to clinical contributorsD Schotte, R Pieters, M L Den Boer
Leukemia|June 25, 2011
Interleukin-27 inhibits pediatric B-acute lymphoblastic leukemia cell spreading in a preclinical modelS Canale, C Cocco, C Frasson, et al.
Leukemia|June 25, 2011
p53 independent epigenetic-differentiation treatment in xenotransplant models of acute myeloid leukemiaK P Ng, Q Ebrahem, S Negrotto, et al.
Leukemia|August 13, 2011
Low frequency of DNMT3A mutations in pediatric AML, and the identification of the OCI-AML3 cell line as an in vitro modelI H I M Hollink, Q Feng, A A Danen-van Oorschot, et al.
Leukemia|August 6, 2011
Dynamics of the emergence of dasatinib and nilotinib resistance in imatinib-resistant CML patientsF X Gruber, T Ernst, K Porkka, et al.
Leukemia|August 10, 2011
Prognostic implications and molecular associations of NADH dehydrogenase subunit 4 (ND4) mutations in acute myeloid leukemiaF Damm, T Bunke, F Thol, et al.
Leukemia|August 24, 2011
The JAK2V617F oncogene requires expression of inducible phosphofructokinase/fructose-bisphosphatase 3 for cell growth and increased metabolic activityM M Reddy, M S Fernandes, A Deshpande, et al.
Leukemia|August 24, 2011
TG02, a novel oral multi-kinase inhibitor of CDKs, JAK2 and FLT3 with potent anti-leukemic propertiesK C Goh, V Novotny-Diermayr, S Hart, et al.
Leukemia|August 27, 2011
Commentary: does immune suppression increase risk of developing acute myeloid leukemia?R P Gale, G Opelz
Leukemia|August 27, 2011
WT1 peptide vaccination following allogeneic stem cell transplantation in pediatric leukemic patients with high risk for relapse: successful maintenance of durable remissionY Hashii, E Sato-Miyashita, R Matsumura, et al.
Pageof 1,398

Showing results (321-330 of 13,978) with videos related to

Sort By:
Pageof 1,398
Leukemia|June 25, 2011
MicroRNAs in acute leukemia: from biological players to clinical contributorsD Schotte, R Pieters, M L Den Boer
Leukemia|June 25, 2011
Interleukin-27 inhibits pediatric B-acute lymphoblastic leukemia cell spreading in a preclinical modelS Canale, C Cocco, C Frasson, et al.
Leukemia|June 25, 2011
p53 independent epigenetic-differentiation treatment in xenotransplant models of acute myeloid leukemiaK P Ng, Q Ebrahem, S Negrotto, et al.
Leukemia|August 13, 2011
Low frequency of DNMT3A mutations in pediatric AML, and the identification of the OCI-AML3 cell line as an in vitro modelI H I M Hollink, Q Feng, A A Danen-van Oorschot, et al.
Leukemia|August 6, 2011
Dynamics of the emergence of dasatinib and nilotinib resistance in imatinib-resistant CML patientsF X Gruber, T Ernst, K Porkka, et al.
Leukemia|August 10, 2011
Prognostic implications and molecular associations of NADH dehydrogenase subunit 4 (ND4) mutations in acute myeloid leukemiaF Damm, T Bunke, F Thol, et al.
Leukemia|August 24, 2011
The JAK2V617F oncogene requires expression of inducible phosphofructokinase/fructose-bisphosphatase 3 for cell growth and increased metabolic activityM M Reddy, M S Fernandes, A Deshpande, et al.
Leukemia|August 24, 2011
TG02, a novel oral multi-kinase inhibitor of CDKs, JAK2 and FLT3 with potent anti-leukemic propertiesK C Goh, V Novotny-Diermayr, S Hart, et al.
Leukemia|August 27, 2011
Commentary: does immune suppression increase risk of developing acute myeloid leukemia?R P Gale, G Opelz
Leukemia|August 27, 2011
WT1 peptide vaccination following allogeneic stem cell transplantation in pediatric leukemic patients with high risk for relapse: successful maintenance of durable remissionY Hashii, E Sato-Miyashita, R Matsumura, et al.
Pageof 1,398